Impact of antibiotic usage on resistance in microorganisms; Urinary tract infections with E-coli as a case in point

Journal of the Pakistan Medical Association

Volumn 54, Issue 9, 2004, Pages 472-475

  Sabir, N ^a   Khan, E ^a   Sheikh, L ^a   Hasan, R ^a  

^a AGA KHAN UNIVERSITY   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; CEFTRIAXONE; COTRIMOXAZOLE; GENTAMICIN; NALIDIXIC ACID; NITROFURANTOIN; OFLOXACIN; PIPEMIDIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM COLONY; BACTERIUM ISOLATE; DRUG USE; ESCHERICHIA COLI; HOSPITAL PHARMACY; PAKISTAN; URINARY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; DEVELOPING COUNTRIES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; FEMALE; HUMANS; LINEAR MODELS; MALE; MICROBIAL SENSITIVITY TESTS; PAKISTAN; PROBABILITY; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY; URINARY TRACT INFECTIONS;

EID: 6344231167     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Sharma AK, Khosla R, Kelaand AK, et al. Fluoroquinolones: antimicrobial agents of 90s. Indian J Pharmacol 1994;26:249-61.
2. Wolfson JS, Hevpev DC. The fluoroquinolones: Structure, mechanisms of resistance and spectrum of activity in vitro. Antimicrob Agents Chemother 1985;28:581-6.
3. Pass RJ, Barnishan J, Ayers LW. Emergence of bacterial resistance to imipenam and ciprofloxacin in a university hospital. J Antimicrob Chemother 1995;36:343-53.
4. Wolfson JS, Hooper DC, Shih DJ, et al. Isolation and characterization of an Escherichia coli strain exhibiting partial tolerance to quinolones. Antimicrob Agents Chemother 1989;33:705-9.
5. Monnet DL. Methicillin-resistant Staphylococcus aureus and its relationship to antimicrobial use: possible implications for control. Infect Control Hosp Epidemiol 1998;19:552-9.
6. Schentag JJ, Hyatt JM, Carr JR, et al. Genesis of methicillin-resistant Staphylococcus aureus (MRSA), how treatment of MRSA infections has selected for vancomycin-resistant Enterococcus faecium, and the importance of antibiotic management and infection control. Clin Infect Dis 1998;26:1204-14.
7. Landman D, Chockalingam M, Quale JM. Reduction in the incidence of methicillin-resistant Staphylococcus aureus and ceftazidime-resistant Klebsiella pneumoniae following changes in a hospital antibiotic formulary. Clin Infect Dis 1999;28:1062-6.
8. Kahlmeter G. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infection: the ECO-SENS project. J Antimicrob Chemother 2003,51:69-76.
9. Kahlmeter G. The ECO-SENS project: a prospective, multinational, multicentric epidemiological survey of prevalence and antimicrobial susceptibility of urinary tract pathogens- interim report. J Antimicrob Chemother 2000;46 (Suppl 1):15-22.
10. Koneman EW, Allen SD, Janda WM, et al. (eds). Color atlas and textbook of diagnostic microbiology, 5th ed. Philadelphia: Lippincott, 1997.
11. Isenberg HD (ed). Clinical microbiology procedures handbook, Vol 1. American Society of Microbiology, Washington DC: 1992.
12. Performance standards for antimicrobial disk susceptibility testing: approved standard 8th ed. Wayne PA. NCCLS doc M2-A8.2003;23:2-16.
13. Stahlmann R, Lode H. Safety overview: toxicity, adverse effects and drug interactions. In: Andriole VT, ed. The Quinolones. London; Academic press; 1988, pp. 201-33.
14. Burkhardt JE, Walterspiel JN, Schaad UB. Quinolone arthropathy in animals versus children. Clin Infect Dis 1997;25:1196-204.
15. Schaad UB. Use of quinolones in pediatrics. Eur J Clin Microbiol Infect Dis 1991;10:355-60.
16. Drago L, De-Vecchi E, Mombelli B, et al. Activity of levofloxacin and ciprofloxacin against urinary pathogens. J Antimicrob Chemother 2001;48:37-45.
17. Stamm WE, Hooton TM. Management of urinary tract infections in adults. N Engl J Med 1993;329:1328-34.
18. Ouabdesselam S, Hooper DC, Tankovic J, et al. Detection of gyrA and gyrB mutations in quinolone-resistant clinical isolates of Escherichia coli by single-strand confonnationai polymorphism analysis and determination of levels of resistance conferred by two different single gyrA mutations. Antimicrob Agents Chemother 1995;39:1667-70.
19. Piddock LVJ, Wise R. Mechanisms of resistance to quinolones and clinical perspectives. J Antimicrob Chemother 1989;23:475-83.
20. Wang M, Tran JH, Jacoby GA, et al. Plasmid mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China. Antimicrob Agents Chemother 2003;47:2242-8.
21. Iqbal M, Patel K, Shah SH, et al. Susceptibility patterns of Escherichia coli prevalence of Multidrug-resistant isolates and extended spectrum beta-lactamase phenotypes. J Pak Med Assoc 2002;52:407-11.
22. Elkins Ca, Nikaido H. Substrate specificity of the RND-type multidrug efflux pumps AcrB and AcrD of Escherichia coli is determined predominantly by two large periplasmic loops. J Bacteriol 2002;184:6490-8.
23. Srikumar R, Kon T, Gotoh N, et al. Expression of Pseudomonas aeruginosa multidrug efflux pumps MexA-MexB-OprM and MexC-MexD-OprJ in a multidrug-sensitive Escherichia coli strain. Antimicrob Agents Chemother 1998;42:65-71.